The present invention relates to a pharmaceutical composition that comprises a compound of formula (I) as active principal ingredient: or a pharmaceutically acceptable salt, isomer, prodrug or solvate thereof; and at least a diluent or binder, wherein the active principle ingredient is present in an amount of at least 80% of the total dry weight of the composition.